Employees: 167
Size Mobia Medical (MOBI) is a United States Health Care company (Medical Specialties) with a market value of $434M, the 2779th largest of 3,085 United States companies the cockpit tracks. Shares closed at $13.03 on 18 Nov 2026.
Performance Over six months the shares gained 2.2%, against -21.1% for the median peer and -2.2% for the United States market (cap-weighted) — 4th highest of 21 in its peer set.
Growth Revenue grew 104.8% over the last twelve months (peer median +1.4%); the operating margin is -144.7% (peer median 6.1%).
Valuation It trades at 8.8× enterprise value to sales against a peer median of 3.9× (3rd most expensive of 19).
Short interest Short interest is 3.0% of the free float (30 Oct 2026).
Next results Next results expected around 3 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | |
|---|---|---|---|
| Revenue | n/a | $32.0M | $15.6M |
| Revenue growth | — | +105% | — |
| Gross profit | n/a | $25.8M | $12.3M |
| EBITDA | n/a | -$46.2M | -$24.1M |
| Net income | n/a | -$46.5M | -$24.6M |
| Free cash flow | n/a | -$46.1M | -$24.4M |
| Capital expenditure | n/a | $364,411 | $40,848 |
| Total debt | $8.37M | $8.44M | $7.72M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | MOBI | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +44.1% | -9.3% | highest of 21 |
| 6-month return | +2.2% | -21.1% | 4th highest of 21 |
| Distance from 52-week high | -14.8% | -44.8% | highest of 21 |
| Revenue growth (TTM) | +104.8% | +1.4% | 2nd highest of 20 |
| Operating margin | -144.7% | 6.1% | 2nd lowest of 20 |
| EV / Sales | 8.8× | 3.9× | 3rd most expensive of 19 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Mobia Medical MOBI | United States | $434M | +2% | +105% | -145% | 8.8× | n/a | n/a |
| Guangzhou Jet Bio-Filtration 688026.SS | China | $436M | +39% | +5% | 11% | 4.8× | 20.6% | +2.2% |
| Shoulder Innovations SI | United States | $432M | +39% | +55% | -54% | 5.5× | n/a | n/a |
| Huaren Pharmaceutical 300110.SZ | China | $440M | -16% | -3% | 6% | 3.3× | 5.8% | +0.3% |
| Revenio REG1V.HE | Finland | $428M | -34% | +44% | 10% | 4.0× | 18.5% | +12.4% |
| China Isotope & Radiation 1763.HK | Hong Kong | $428M | -41% | -5% | 13% | n/a | n/a | n/a |
| Hunan Sundy Science and Technology 300515.SZ | China | $425M | -16% | +10% | 27% | 3.5× | -0.1% | +15.6% |
| Clarity Pharmaceuticals CU6.AX | Australia | $444M | -33% | n/a | n/a | n/a | n/a | n/a |
| Ningbo Tianyi Medical Appliance 301097.SZ | China | $418M | -22% | +46% | 8% | 4.4× | n/a | n/a |
| Shanghai Kindly Enterprises Development 603987.SS | China | $452M | -12% | 0% | 10% | 1.5× | -1.0% | -2.8% |
| Guangdong Shirongzhaoye 002016.SZ | China | $453M | -26% | -31% | 3% | 3.8× | 21.5% | -11.7% |
| Jenscare Scientific 9877.HK | Hong Kong | $415M | -32% | +993% | -106% | 17.8× | n/a | n/a |
| PROTEINA 468530.KS | South Korea | $460M | +5% | -59% | -1,178% | 410.3× | n/a | n/a |
| Beijing Leadman Biochemistry 300289.SZ | China | $460M | -9% | +46% | 1% | 8.2× | 36.0% | -6.9% |
| MiMedx MDXG | United States | $464M | -16% | -23% | -8% | 1.1× | 10.9% | +11.0% |
| Chison Medical Technologies 688358.SS | China | $406M | -27% | -1% | 19% | 3.9× | 9.6% | +5.6% |
| Eiken Chemical 4549.T | Japan | $466M | -20% | +4% | 6% | 1.6× | n/a | n/a |
| Shanghai Titan Scientific 688133.SS | China | $403M | -26% | +1% | -6% | 1.4× | n/a | n/a |
| WELL LEAD MEDICAL 603309.SS | China | $473M | -22% | +1% | 15% | 2.0× | -5.9% | +7.7% |
| Guanhao Biotech 300238.SZ | China | $397M | -26% | -12% | 3% | 7.1× | n/a | n/a |
| AngioDynamics ANGO | United States | $476M | -4% | +8% | -6% | 1.4× | n/a | n/a |